Carnes Martha Z. 4
4 · Core Laboratories Inc. /DE/ · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Carnes Martha Z.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-04-01+9,317→ 46,328 total - Exercise/Conversion
Restricted Shares
2025-04-01−9,317→ 0 totalExercise: $0.00→ Common Stock (9,317 underlying) - Award
Restricted Shares
2025-04-01+8,069→ 8,069 totalExercise: $0.00→ Common Stock (8,069 underlying)
Footnotes (2)
- [F1]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance.
- [F2]The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025.